English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/214705
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:


G protein-coupled receptor kinase 2 (GRK2) as a potential therapeutic target in cardiovascular and metabolic diseases

AuthorsMurga, Cristina ; Arcones, Alba C.; Cruces-Sande, Marta ; Briones, Ana M.; Salaices, Mercedes; Mayor Méndez, Federico Jr.
Insulin resistance
Issue Date19-Feb-2019
CitationFrontiers in Pharmacology 10 (2019)
AbstractG protein-coupled receptor kinase 2 (GRK2) is a central signaling node involved in the modulation of many G protein-coupled receptors (GPCRs) and also displaying regulatory functions in other cell signaling routes. GRK2 levels and activity have been reported to be enhanced in patients or in preclinical models of several relevant pathological situations, such as heart failure, cardiac hypertrophy, hypertension, obesity and insulin resistance conditions, or non-alcoholic fatty liver disease (NAFLD), and to contribute to disease progression by a variety of mechanisms related to its multifunctional roles. Therefore, targeting GRK2 by different strategies emerges as a potentially relevant approach to treat cardiovascular disease, obesity, type 2 diabetes, or NAFLD, pathological conditions which are frequently interconnected and present as co-morbidities.
Publisher version (URL)http://dx.doi.org/10.3389/fphar.2019.00112
Identifiersdoi: 10.3389/fphar.2019.00112
issn: 1663-9812
Appears in Collections:(CBM) Artículos
Files in This Item:
File Description SizeFormat 
MayorJrF_G Protein-Coupled.pdf1,72 MBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.